Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug:68:102655.
doi: 10.1016/j.amsu.2021.102655. Epub 2021 Aug 6.

COVID-19 and mucormycosis superinfection: Exploring the missing pathophysiological links

Talal Almas  1 , Waqas Nazar  2 , Tarek Khedro  1 , M Ali Kanawati  1 , Alishba Adnan  3 , Mohammad Almuhaileej  1 , Abdulaziz Alshamlan  1 , Abdulaziz Abdulhadi  1 , Kuvira T Manamperi  1 , Saba Sarfraz  4
Affiliations
Review

COVID-19 and mucormycosis superinfection: Exploring the missing pathophysiological links

Talal Almas et al. Ann Med Surg (Lond). 2021 Aug.

Abstract

The coronavirus disease 2019 continues to unearth new facets that portend grave clinical implications. In recent times, there has been mounting fervor regarding coronavirus disease 2019 and mucormycosis superinfection. While the correlation between the two is conspicuous, the underlying pathophysiological mechanisms that render a patient with coronavirus disease 2019 susceptible to mucormycosis, or vice versa, are still elusive.

Keywords: COVID-19; Immunosupression; Morbidity; Mortality; Mucormycosis.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Pandiar D., Kumar N.S., Anand R., Kamboj M., Narwal A., Shameena P.M. Does COVID 19 generate a milieu for propagation of mucormycosis? Med. Hypotheses. 2021 Jul;152:110613. doi: 10.1016/j.mehy.2021.110613. Epub 2021 May 26. PMID: 34087613; PMCID: PMC8152198. - DOI - PMC - PubMed
    1. Almas T., Ehtesham M., Khedro T., Haadi A., Nabeel A.R., Hussain S. The many faces of coronavirus disease 2019: COVID-19 and the liver. Ann Med Surg (Lond) 2021 Apr;64:102224. doi: 10.1016/j.amsu.2021.102224. Epub 2021 Mar 15. PMID: 33747505; PMCID: PMC7959700. - DOI - PMC - PubMed
    1. Skiada A., Lass-Floerl C., Klimko N., Ibrahim A., Roilides E., Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med. Mycol. 2018 Apr;56(suppl_1):93–101. doi: 10.1093/mmy/myx101. 1. PMID: 29538730; PMCID: PMC6251532. - DOI - PMC - PubMed
    1. Pasero D., Sanna S., Liperi C., Piredda D., Branca G.P., Casadio L. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection. 2020 Dec:1–6. doi: 10.1007/s15010-020-01561-x. 17. Epub ahead of print. PMID: 33331988; PMCID: PMC7745708. - DOI - PMC - PubMed
    1. Sharma S., Grover M., Bhargava S., Samdani S., Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J. Laryngol. Otol. 2021 May;135(5):442–447. doi: 10.1017/S0022215121000992. Epub 2021 Apr 8. PMID: 33827722; PMCID: PMC8060545. - DOI - PMC - PubMed